Two Instruments to Determine Activated Partial Thromboplastin Time: Implications for Heparin Monitoring
- 1 April 1999
- journal article
- clinical trial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 19 (4) , 383-387
- https://doi.org/10.1592/phco.19.6.383.31039
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Heparin and Low-Molecular-Weight HeparinChest, 1998
- Lactate and point-of-care testingCritical Care Medicine, 1998
- Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assaysArchives of internal medicine (1960), 1997
- Activated Clotting Time Versus Activated Partial Thromboplastin Time for Therapeutic Monitoring of HeparinAnnals of Pharmacotherapy, 1995
- Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitorCritical Care Medicine, 1995
- Comparison of bedside and hospital laboratory coagulation studies during and after coronary interventionCatheterization and Cardiovascular Diagnosis, 1995
- Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: A coronary care unit experienceAmerican Heart Journal, 1994
- Intravenous heparin dosingJournal of General Internal Medicine, 1993
- Establishing a Therapeutic Range for Heparin TherapyAnnals of Internal Medicine, 1993
- Physician practices in the treatment of pulmonary embolism and deep venous thrombosisArchives of internal medicine (1960), 1988